Skip to main content
Clinical Trials/ACTRN12618001099213
ACTRN12618001099213
Not yet recruiting
Phase 3

Prospective randomised assessor blinded pilot study comparing Hyperbaric Oxygen therapy with PENTOCLO for the management of Osteoradionecrosis of the mandible.

Dr Emma Lewis0 sites16 target enrollmentJuly 2, 2018

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
osteoradionecrosis of the mandible
Sponsor
Dr Emma Lewis
Enrollment
16
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 2, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Emma Lewis

Eligibility Criteria

Inclusion Criteria

  • – Patients diagnosed with ORN by an Oral and Maxillofacial surgeon
  • \- Patients or proxies that are able to give informed consent

Exclusion Criteria

  • – Patients that have spontaneously healing ORN
  • \-Patients that have undergone previous treatment for ORN (PENTO, HBO or surgery).
  • \-Patients or proxies that are unable to give informed consent
  • \-Patients that are pregnant at the time of therapy
  • \-Patients that have received previous anti\-resorptive or anti\-angiogenic medications
  • \-Patients requiring further surgical management for their Head and Neck cancer during the study period
  • \-Patients diagnosed with ORN requiring urgent surgery
  • \-Patients that are unable to be randomised

Outcomes

Primary Outcomes

Not specified

Similar Trials